DBGen regularly participates in the international External Quality Assessment (EQA)/Proficiency Testing (PT) schemes of the Genomics Quality Assessment (GenQA), a member of UK NEQAS Consortium, to ensure clinical diagnostics and technical competency and proficiency. DBGen was awarded the highest rating in the 2019 Retinal Disorders, 2020 Eye Disorders and 2021 Eye Disorders EQAs.